Home » Topics » Conferences

Conferences
RSS

RPR-130737, a potent nonpeptidyl inhibitor of factor Xa

April 7, 1998

Merck & Co. designates thrombin inhibitor for clinical development

April 7, 1998

Pfizer NK1 antagonist and ondansetron provide synergistic antiemetic efficacy in clinical trials

April 7, 1998

Early clinical trial evaluates orbofiban pharmacodynamics

April 7, 1998

First clinical trials performed with BMS-181885

April 7, 1998

Phase Ib results reported for allosteric Hb modifier RSR13

April 7, 1998

Novel antisecretory/antiulcer agent from Shionogi undergoes evaluation in Japan

April 7, 1998

YM-905 shows promising activity in animal model of IBS

April 6, 1998

YM-905 shows promise as safe and effective treatment for overactive detrusor

April 6, 1998

Genetronics' EPT plus bleomycin looks effective in prostate cancer

April 6, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...